Suppression of Tumorigenesis: Modulation of Inflammatory Cytokines by Oral Administration of Microencapsulated Probiotic Yogurt Formulation
Authors:
Open Access
- 1 January 2010
- journal article
- Published by Wiley in International Journal of Inflammation
- Vol. 2010, 1-10
Abstract
The objective of this study was to examine the ability of a novel microencapsulated probiotic yogurt formulation to suppress the intestinal inflammation. We assessed its anticancer activity by screening interleukin-1, 6, and 12 (IL-1, 6, 12), secretory levels of tumor necrosis factor-alpha (TNF-), interferon-gamma (IFN-), prostaglandin, and thromboxane B2 in the digesta obtained from the duodenum, jejunum, proximal, and distal segments of the ileum of C57BL/6J-/J mice. Formulation-receiving animals showed consistently lower proinflammatory cytokines' levels when compared to control group animals receiving empty alginate-poly-L-lysine-alginate (APA) microcapsules suspended in saline. The concentrations of IL-12 found in serum in control and treatment group animals were significant: pg/mL and pg/mL for control and treatment animals, respectively. We determined a significant change in plasma C-reactive protein: ng/mL in control group and ng/mL in treatment group. Western blots showed a 71% downregulation of cyclooxygenase-2 (COX-2) protein in treatment group animals compared to control. These results point to the possibility of using this yogurt formulation in anticancer therapies, in addition to chronic gut diseases such as Crohn's disease, irritable bowel syndrome (IBS), and inflammatory bowel disease (IBD) thanks to its inflammation lowering properties.
Keywords
Funding Information
- Canadian Institute of Health Research (CIHR-MOP-64308)
This publication has 54 references indexed in Scilit:
- PGE2inhibits apoptosis in human adenocarcinoma Caco-2 cell line through Ras-PI3K association and cAMP-dependent kinase A activationAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2007
- The involvement of IL-1 in tumorigenesis, tumor invasiveness, metastasis and tumor-host interactionsCancer and Metastasis Reviews, 2006
- Regulation of stromal cell cyclooxygenase-2 in the Apc Min/+ mouse model of intestinal tumorigenesisCarcinogenesis, 2005
- Prostaglandin E2 Regulates the Complement Inhibitor CD55/Decay-accelerating Factor in Colorectal CancerJournal of Biological Chemistry, 2005
- Oncostatin M synergises with house dust mite proteases to induce the production of PGE2 from cultured lung epithelial cellsBritish Journal of Pharmacology, 2000
- Network of inflammatory cytokines and correlation with disease activity in ulcerative colitisAmerican Journal of Gastroenterology, 1998
- The effect of lactulose on DNA damage induced by DMH in the colon of human flora‐associated ratsNutrition and Cancer, 1996
- Multiple Intestinal Neoplasia Caused by a Mutation in the Murine Homolog of the APC GeneScience, 1992
- Enhanced production of interleukin 1-beta by mononuclear cells isolated from mucosa with active ulcerative colitis of Crohn's disease.Gut, 1989
- Probiotics in man and animalsJournal of Applied Bacteriology, 1989